These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37710023)

  • 1. Human protozoa infection and dysplasia in ulcerative colitis: a neglected aspect in a prominent disease.
    Abdel Hamed EF; Mostafa NE; Farag SM; Ibrahim MN; Ibrahim BH; Rashed HE; Radwan M; Mohamed SY; El Hendawy R; Fawzy EM
    Parasitol Res; 2023 Nov; 122(11):2709-2718. PubMed ID: 37710023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 antibodies, metallothioneins, and oxidative stress markers in chronic ulcerative colitis with dysplasia.
    Hamouda HE; Zakaria SS; Ismail SA; Khedr MA; Mayah WW
    World J Gastroenterol; 2011 May; 17(19):2417-23. PubMed ID: 21633642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis.
    Xiang JY; Ouyang Q; Li GD; Xiao NP
    World J Gastroenterol; 2008 Jan; 14(1):53-7. PubMed ID: 18176961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis.
    Lee SH; Kim MJ; Chang K; Song EM; Hwang SW; Park SH; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yang SK; Ye BD
    BMC Gastroenterol; 2017 Oct; 17(1):110. PubMed ID: 29061121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of calprotectin in colon mucosa and fecal of patients with ulcerative colitis].
    Liu WB; Lü YM; Jin Z; Yang XL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Apr; 37(2):179-82. PubMed ID: 15841150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum p53 antibodies in patients affected with ulcerative colitis.
    Cioffi M; Riegler G; Vietri MT; Pilla P; Caserta L; Carratù R; Sica V; Molinari AM
    Inflamm Bowel Dis; 2004 Sep; 10(5):606-11. PubMed ID: 15472522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid fecal calprotectin test for prediction of mucosal inflammation in ulcerative colitis and Crohn disease: a prospective cohort study.
    Moniuszko A; Głuszek S; Rydzewska G
    Pol Arch Intern Med; 2017 May; 127(5):312-318. PubMed ID: 28442699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal MMP-9: a new noninvasive differential diagnostic and activity marker in ulcerative colitis.
    Annaházi A; Molnár T; Farkas K; Rosztóczy A; Izbéki F; Gecse K; Inczefi O; Nagy F; Földesi I; Szűcs M; Dabek M; Ferrier L; Theodorou V; Bueno L; Wittmann T; Róka R
    Inflamm Bowel Dis; 2013 Feb; 19(2):316-20. PubMed ID: 22550024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of serum p53 antibodies in patients with ulcerative colitis and its carcinogenesis.
    Yoshizawa S; Matsuoka K; Inoue N; Takaishi H; Ogata H; Iwao Y; Mukai M; Fujita T; Kawakami Y; Hibi T
    Inflamm Bowel Dis; 2007 Jul; 13(7):865-73. PubMed ID: 17285596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Histological remission of ulcerative colitis with combined anti-cytokine and cell therapy].
    Knyazev OV; Khomeriki SG; Kagramanova AV; Lishchinskaya AA; Smirnova OA; Noskova KK; Parfenov AI
    Ter Arkh; 2021 Dec; 93(12):1435-1442. PubMed ID: 36286670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal calprotectin is a clinically relevant biomarker of mucosal healing in patients with quiescent ulcerative colitis.
    Yamaguchi S; Takeuchi Y; Arai K; Fukuda K; Kuroki Y; Asonuma K; Takahashi H; Saruta M; Yoshida H
    J Gastroenterol Hepatol; 2016 Jan; 31(1):93-8. PubMed ID: 26212346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble syndecan-1 as marker of intestinal inflammation: A preliminary study and evaluation of a new panel of biomarkers for non-invasive prediction of active ulcerative colitis.
    Floer M; Clausen M; Meister T; Vollenberg R; Bettenworth D; Tepasse PR
    Adv Clin Exp Med; 2021 Jul; 30(7):655-660. PubMed ID: 34286513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rectal dialysate and fecal concentrations of neutrophil gelatinase-associated lipocalin, interleukin-8, and tumor necrosis factor-alpha in ulcerative colitis.
    Nielsen OH; Gionchetti P; Ainsworth M; Vainer B; Campieri M; Borregaard N; Kjeldsen L
    Am J Gastroenterol; 1999 Oct; 94(10):2923-8. PubMed ID: 10520846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leucine-Rich Alpha-2 Glycoprotein Is a Reliable Serum Biomarker for Evaluating Clinical and Endoscopic Disease Activity in Inflammatory Bowel Disease.
    Shimoyama T; Yamamoto T; Yoshiyama S; Nishikawa R; Umegae S
    Inflamm Bowel Dis; 2023 Sep; 29(9):1399-1408. PubMed ID: 36334015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes.
    Schoepfer AM; Beglinger C; Straumann A; Safroneeva E; Romero Y; Armstrong D; Schmidt C; Trummler M; Pittet V; Vavricka SR
    Inflamm Bowel Dis; 2013 Feb; 19(2):332-41. PubMed ID: 23328771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein/albumin ratio and IL-6 are associated with disease activity in patients with ulcerative colitis.
    Feng W; Zhu L; Liu Y; Xu L; Shen H
    J Clin Lab Anal; 2023 Feb; 37(3):e24843. PubMed ID: 36725336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis.
    Singh S; Ananthakrishnan AN; Nguyen NH; Cohen BL; Velayos FS; Weiss JM; Sultan S; Siddique SM; Adler J; Chachu KA;
    Gastroenterology; 2023 Mar; 164(3):344-372. PubMed ID: 36822736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease.
    Hoekman DR; Diederen K; Koot BG; Tabbers MM; Kindermann A; Benninga MA
    Eur J Pediatr; 2016 Oct; 175(10):1335-42. PubMed ID: 27573259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of fecal calprotectin as a marker of intestinal inflammation in patients with ulcerative colitis.
    Önal İK; Beyazit Y; Şener B; Savuk B; Özer Etık D; Sayilir A; Öztaş E; Torun S; Özderın Özın Y; Tunç Demırel B; Ülker A; Dağli Ü
    Turk J Gastroenterol; 2012; 23(5):509-14. PubMed ID: 23161295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal calprotectin and ulcerative colitis endoscopic activity index as indicators of mucosal healing in ulcerative colitis.
    Taghvaei T; Maleki I; Nagshvar F; Fakheri H; Hosseini V; Valizadeh SM; Neishaboori H
    Intern Emerg Med; 2015 Apr; 10(3):321-8. PubMed ID: 25366383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.